Accelerate Your Small Molecule Program with Syngene
Your end-to-end partner for small molecule drug discovery, development, and manufacturing – from idea to launch.
Confidence of global pharma leaders in Syngene.
Trusted by leading pharmaceutical and biotech organizations for our consistent, high-standard delivery
- Trusted by leading global pharma and biotech companies
- Advanced Technology Platforms
- Proven Operational Excellence
- Strong Regulatory Track Record
- Comprehensive End-to-End Services
Stop Stalling. Start Accelerating. Your Molecule’s Path to Market.
Our Integrated Capabilities
Syngene offers end-to-end capabilities for small molecule drug discovery, development, and manufacturing via our SynVent Platform, removing friction and enabling speed from development to commercial manufacturing.
Build a Robust & Scalable API Process, Faster
Develop scalable, green-chemistry processes for APIs – including HPAPIs – with robust synthesis routes, method validation, and GMP manufacturing. Flow Chemistry platforms enhance efficiency and safety, helping you scale quickly.
Transform Your Molecule into a Successful Drug Product
Solve solubility challenges, create patient-centric dosage forms, and apply solid-state characterization for stable, consistent formulations.
Get the Data You Need to Move Forward with Confidence
Broad catalytic processes (metal-catalysed C–C bond formations, asymmetric chiral inductions, hydrogenation, oxidation, epoxidation, methylation)
Ensure Sterility & Integrity for Your Parenteral Drug
Advanced sterile-fill suites, lyophilization expertise, and flexible filling lines for vials and PFS.
Build a Robust & Scalable API Process, Faster
Develop scalable, green-chemistry processes for APIs – including HPAPIs – with robust synthesis routes, method validation, and GMP manufacturing. Flow Chemistry platforms enhance efficiency and safety, helping you scale quickly.
Beyond Small Molecules – Integrated Support for New Modalities
Expertise Across Therapeutic Modalities
Syngene extends its expertise into emerging modalities:
Peptide Development
SPPS, purification, and analytical characterization.
Oligonucleotides
cGMP manufacturing, analytical testing, and development support.
PROTACs
PROTAC and X-TAC platforms enabling targeted protein degradation across the drug development cycle
The Syngene Advantage: Reliable Delivery, Rooted in Scientific Precision.
Providing confidence through a balanced integration of scientific depth and operational reliability.
Integrated End-to-End Platform
SynVent accelerates development by combining discovery, development, and manufacturing under one roof.
Operational Efficiency
Co-located services minimize transfers, costs, and delays.
Proven Track Record
30+ years, 5600 scientists, long-term partnerships with Baxter, BMS, and more.
Deep Scientific Expertise
Advanced technologies and scientific depth across all phases.
Global Quality & Compliance
Inspections passed from FDA, EMA, PMDA, and MHRA.
Flexible & Collaborative Partnerships
Engagement models tailored to your program goals.
Your Next Breakthrough Starts Here
No more fragmented outsourcing – experience Syngene’s fully integrated CDMO services.